I would like clarification of the Preventive Medicine Services codes. Would it be appropriate to use these codes to report routine scheduled follow-up care, or visits requested by the physician, one or more years following the removal of a tumor, when there are no patient complaints and no evidence of recurrence? If so, is there a recommended time period following the successful treatment of the cancer in which the scheduled follow-up visits would be considered routine? ...
Subscribe or sign in to view the full article.
Article Overview
This article addresses a common coding question about whether routine, asymptomatic follow-up encounters after tumor removal should be treated as preventive medicine services or as evaluation and management visits. It is relevant to coders, billers, and clinical staff who work with oncology follow-up, preventive care reporting, and diagnosis selection. The discussion focuses on the type of visit, the clinical context after cancer treatment, and the role of physician judgment in determining the appropriate general category of service.
Why This Topic Matters
Correctly classifying follow-up encounters affects how routine surveillance and preventive services are reported in post-cancer care settings. The article helps readers understand the broad distinction between preventive services and office or outpatient evaluation and management visits.
What You Will Learn
- How this topic distinguishes preventive medicine services from follow-up visits after cancer treatment
- What general factors influence the reporting approach for asymptomatic post-treatment encounters
- How physician judgment relates to the timing of routine surveillance after successful cancer treatment
- Why diagnosis context matters in post-treatment follow-up coding
Who Should Read This
- Medical coders
- Billing staff
- Revenue cycle teams
- Clinical documentation staff
- Oncology practice staff
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com